KS

Kavita Singh

Active Director Director DIN 02311386
DIN 02311386 First appointment Sep 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2008
Shareholding value •••• Premium profile

About Kavita Singh

Data last updated:

Kavita Singh is a Director at Vench Mark Healthcare Private Limited (since 2008). The company operates in Pharma. Vench Mark Healthcare Private Limited reported revenue of ₹1.59 Cr (FY 2025).

DIN 02311386
Primary Designation Director
Industry Pharma
First Appointment 04 Sep 2008
Oldest Company Age 18 yrs
Largest company Vench Mark Healthcare Private Limited · ₹1.59 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Sep 20082008₹1.59 Cr (FY 2025)Active

Board colleagues of Kavita Singh

NameDINCompanyDesignation
Dhananjay Singh02311369Vench Mark Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vench Mark Healthcare Private Limited
Premium access

Shareholding and investment profile for Kavita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavita Singh

Kavita Singh currently holds 1 directorship: Vench Mark Healthcare Private Limited (Director, since 04 Sep 2008, revenue ₹1.59 Cr (FY 2025)).

Kavita Singh was first appointed on 04 Sep 2008 as Director at Vench Mark Healthcare Private Limited.

The current boards of Kavita Singh's companies include Dhananjay Singh (Vench Mark Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available